Aquinox to Present at LEERINK Partners 5th Annual Global Healthcare Conference
January 28, 2016 09:15 ET
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Jan. 28, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Announces Update on Development Program for AQX-1125 Following Meeting With FDA
January 11, 2016 07:00 ET
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Closing of Initial Public Offering
March 12, 2014 12:58 ET
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, March 12, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (Nasdaq:AQXP) announced today the closing of its initial public offering of 4,830,000 shares of its...
Aquinox Pharmaceuticals Prices Initial Public Offering
March 07, 2014 09:00 ET
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, March 7, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. announced today the pricing of its initial public offering of 4,200,000 shares of its common stock at a...